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Background: The mechanisms for the relationship between particulate air pollution and cardiac disease are not
fully understood. Air pollution-induced myocardial ischemia is one of the potentially important mechanisms.
Methods: We investigate the acute effects and the time course of fine particulate pollution (PM2.5) on myocardium
ischemic injury as assessed by ST-segment height in a community-based sample of 106 healthy non-smokers.
Twenty-four hour beat-to-beat electrocardiogram (ECG) data were obtained using a high resolution 12-lead Holter
ECG system. After visually identifying and removing all the artifacts and arrhythmic beats, we calculated beat-to-
beat ST-height from ten leads (inferior leads II, III, and aVF; anterior leads V3 and V4; septal leads V1 and V2; lateral
leads I, V5, and V6,). Individual-level 24-hour real-time PM2.5 concentration was obtained by a continuous personal
PM2.5 monitor. We then calculated, on a 30-minute basis, the corresponding time-of-the-day specific average
exposure to PM2.5 for each participant. Distributed lag models under a linear mixed-effects models framework were
used to assess the regression coefficients between 30-minute PM2.5 and ST-height measures from each lead; i.e.,
one lag indicates a 30-minute separation between the exposure and outcome.
Results: The mean (SD) age was 56 (7.6) years, with 41% male and 74% white. The mean (SD) PM2.5 exposure was
14 (22) μg/m
3. All inferior leads (II, III, and aVF) and two out of three lateral leads (I and V6), showed a significant
association between higher PM2.5 levels and higher ST-height. Most of the adverse effects occurred within two
hours after PM2.5 exposure. The multivariable adjusted regression coefficients b (95% CI) of the cumulative effect
due to a 10 μg/m
3 increase in Lag 0-4 PM2.5 on ST-I, II, III, aVF and ST-V6 were 0.29 (0.01-0.56) μV, 0.79 (0.20-1.39)
μV, 0.52 (0.01-1.05) μV, 0.65 (0.11-1.19) μV, and 0.58 (0.07-1.09) μV, respectively, with all p < 0.05.
Conclusions: Increased PM2.5 concentration is associated with immediate increase in ST-segment height in inferior
and lateral leads, generally within two hours. Such an acute effect of PM2.5 may contribute to increased potential
for regional myocardial ischemic injury among healthy individuals.
Background
Numerous studies have consistently found a significant
association between exposures to fine particulate matter,
defined as fine particles with aerodynamic diameter less
or equal to 2.5 micrometers (PM2.5), and the risk of
clinical cardiovascular disease (CVD) [1-4]. The
mechanisms responsible for such an association have
been the focus of recent environmental health studies.
Several studies [5-10] have suggested that electrocardio-
graphic (ECG) morphologies indicative of myocardial
ischemic damages are significantly associated with
short-term increases in PM levels, thus air pollution-
induced myocardial ischemia is one of the potentially
important mechanisms. No studies have been published
documenting the exact time course of action from
PM2.5 exposure to myocardial ischemia. On the other
hand, ST-height changes, including both ST depression
and elevation, generally have been accepted as indicators
of myocardial ischemic injury [11,12]. We therefore
designed this study to systematically investigate the
effects and the time course of individual-level exposures
to PM2.5 on the ST-height, an ECG marker of myocar-
dial ischemia, in a community-based sample of middle-
aged adults.
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Study Design
For this report, we used the data collected for the Air
Pollution and Cardiac Risk and its Time Course
(APACR) study, which we designed to investigate the
mechanisms and the time course of the adverse effects
of PM2.5 on cardiac electrophysiology, blood coagula-
tion, and systemic inflammation. Recruitment methods
and examination procedures for the APACR study have
been published elsewhere [13,14]. Briefly, all study parti-
cipants were recruited from communities in central
Pennsylvania, primarily from the Harrisburg metropoli-
tan area. All participants gave written informed consent
prior to their participation in the study. The inclusion
criteria for the study included nonsmoking adults ≥ 45
years old who had not been diagnosed with severe car-
diac problems (defined as diagnosed valvular heart dis-
ease, congenital heart disease, acute myocardial
infarction or stroke within six months, or congestive
heart failure). Community recruitment specialists from
the Pennsylvania State University General Clinical
Research Center (GCRC), which is funded by the
National Institutes of Health, at the Penn State College
of Medicine, and the GCRC-organized community out-
reach activities, supported the recruitment of the partici-
pants. The GCRC maintains a list of individuals who
live in central Pennsylvania communities for various
health-related studies. Approximately 75% of the indivi-
duals who were contacted and who met our inclusion
criteria were enrolled in the APACR study. Our targeted
sample size was 100 individuals, and we enrolled and
examined 106 individuals for the APACR study. The
examination of two participants per week was con-
ducted from November 2007 to June 2009 for the entire
examination period except for major holidays.
Study participants were examined in the GCRC in the
morning between 8:00 AM and 10:00 AM on Day-1. All
participants fasted for at least eight hours before the
clinical examination. After completing a health history
questionnaire, a trained research nurse measured seated
blood pressure three times, height, and weight, and
drew 50 mL of blood for biomarker assays according to
the blood sample preparation protocols. A trained inves-
tigator connected the PM2.5 and Holter ECG recorders.
Participants were given an hourly activity log to record
special events that occurred over the next 24 hours,
including outdoor activities, exposure to traffic on the
street, traveling in an automobile, and any physical
activities. The entire clinical examination session lasted
about one hour. Participants were then released to pro-
ceed with their usual daily routines. The next morning,
the participants returned to the GCRC to remove the
PM2.5 and Holter monitors, deliver the completed
activity log, have another 50 mL of blood drawn, and a
urine sample collected. Then, an exercise echocardiogra-
phy was performed on each participant according to a
standardized protocol to measure the participant’sv e n -
tricular function and structure. The entire Day-2 session
lasted for about one hour and 45 minutes. Penn State
University College of Medicine Institutional Review
Board approved the study protocol.
Personal PM2.5 Exposures
The APACR study used a personal PM2.5 DataRam
(pDR, model 1200, Thermo Scientific, Boston, MA) for
real-time 24-hour personal PM2.5 exposure assessment.
Details of the exposure assessment [13,14] and of the
instrument’s performance have been reported elsewhere
[15-18]. Real-time PM2.5 concentrations were initially
recorded at one-minute intervals. For each participant,
we calculated the 30-minute segment-specific averages,
based on the whole and half hours, as our PM2.5 expo-
sure variable in the APACR study. Therefore, the PM2.5
exposure variables were treated as repeated measures,
and each individual contributed 48 exposure data points.
Continuous Ambulatory ECG and ST-Height Variables
A high-fidelity (sampling frequency 1,000 Hz) 12-lead
HScribe Holter System (Mortara Instrument, Inc., Mil-
waukee, WI) was used to collect the 24-hour Holter beat-
to-beat ECG data. The high-fidelity ECG significantly
increases the resolution and enhances the accuracy of
various wave form measurements. The details of the Hol-
ter ECG data collection and reading have been published
[13,14]. Relevant to this report, the Holter ECG data are
scanned to a designated computer for offline processing
by an experienced investigator using modified Holter
System software and the SuperECG software (also devel-
oped by Mortara Instrument, Inc.). The main objectives
of the offline processing were to verify the Holter-identi-
fied ECG waves, to identify and label additional electro-
nic artifacts and arrhythmic beats in the ECG recording,
and to perform beat-to-beat ECG analysis to calculate
various ECG waveform parameters, including ST seg-
ment height. The calculated ST-height included beat-to-
beat ST-height from ten leads (inferior leads II, III, and
aVF; lateral leads I, V5, and V6; septal leads V1 and V2;
and anterior leads V3 and V4), defined as the distance
between the J point, and 60 ms after J point. We then cal-
culated on a 30-minute basis the average ST-height for
each lead. Therefore, the ST-height measures are treated
as repeated outcome measures, and each individual con-
tributed 48 data points for each of the ten leads. Correla-
tion coefficients [19] for the ST-height measures
obtained from ten leads were presented in Table 1. The
ST-heights in inferior leads were highly correlated.
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We performed time and frequency domain HRV analy-
sis on the ECG recording, after removing artifacts with
standardized visual inspection and statistical filters. We
calculated HRV indices from 30-minute segment-speci-
fic recordings using the SuperECG package (Mortara
Instrument, Inc., Milwaukee, WI) according to current
recommendations [20], and used the following HRV
indices as measures of cardiac autonomic modulation
(CAM): standard deviation of all RR intervals (SDNN,
ms), square root of the mean of the sum of the squares
of differences between adjacent RR (RMSSD, ms), power
in the low frequency range (0.04-0.15 Hz, LF), power in
the high frequency range (0.15-0.40 Hz, HF), and the
ratio of LF and HF (LF/HF).
Weather Variables
We obtained individual-level real-time temperature and
relative humidity using the HOBO H8 logger (Onset
Computer Corporation, Bourne, MA). The real-time
temperature and relative humidity were recorded at
one-minute intervals initially. For each participant, we
calculated 30-minute segment specific averages, corre-
sponding to the PM2.5 and Holter measures. Therefore,
these weather covariables are treated as repeated mea-
sures, and each individual contributed 48 data points for
each variable.
Other Participant-Level Covariables
A standardized questionnaire administered on Day-1 of
the study was used to collect the following individual-
level information: (a) demographic variables, including
age, race, sex, and highest education level; (b) medica-
tion uses, including anti-anginal medication, anti-hyper-
tensive medication, and anti-diabetic medication; and (c)
physician diagnosed chronic disease history, including
CVD (including revascularization procedures and myo-
cardial infarction), hypertension, and diabetes. The
averages of the second and third measures of seated
systolic and diastolic blood pressures on Day-1 were
used to represent a participant’s blood pressure levels.
Day-1 fasting glucose was measured by Penn State
GCRC central laboratory. CVD was defined by anti-
anginal medication use or a history of CVD. Hyperten-
sion was defined by anti-hypertensive medication use,
physician diagnosed hypertension, systolic blood pres-
sure ≥ 140 mmHg, or diastolic blood pressure ≥ 90 mm
Hg. Diabetes was defined by anti-diabetic medication
use, physician diagnosed diabetes, or fasting glucose ≥
126 mg/dl. Body mass index (BMI) was defined as the
ratio of weight to height squared (BMI, kg/m
2).
Statistical Analysis
Two-sample t tests or chi-square tests, as appropriate,
were used to compare the distributions of basic demo-
graphic variables between participants with and without
chronic diseases. We perform a repeated measures ana-
lysis using distributed lag models [21-23] under a linear
mixed-effects models [24,25] framework, specifying a
first-order autoregressive covariance structure to model
the correlation between observations from the same par-
ticipant, to estimate the regression coefficients between
30-minute PM2.5 and the ST-height measures. Time was
included as a categorical variable to allow flexibility in
modeling the relationship between ST-height measures
and time. Residual diagnostics were used to assess the
appropriateness of modeling assumptions, including
normality and homogeneity of variance, and no sizeable
departures were detected. In these models, one lag indi-
cates a 30-minute separationb e t w e e nt h ee x p o s u r ea n d
outcome. Thus, Lag 0 indicates the spontaneous rela-
tionships between PM2.5 and the ST-height, and Lag 1
indicates 30 minutes between the PM2.5 and ST-height,
and so on. We chose a constrained distributed lag
model, the polynomial distributed lag model, to reduce
the potential collinearity of PM2.5 between individual
lags using a second-degree polynomial. The linear
mixed-effects model framework was chosen because it
Table 1 Correlation coefficients for ST-height measurements
ST-I ST-II ST-III ST-aVF ST-V1 ST-V2 ST-V3 ST-V4 ST-V5 ST-V6
ST-I 1.00
ST-II 0.62 1.00
ST-III 0.21 0.90 1.00
ST-aVF 0.44 0.98 0.97 1.00
ST-V1 -0.03 -0.12 -0.13 -0.13 1.00
ST-V2 0.52 0.35 0.14 0.26 0.68 1.00
ST-V3 0.49 0.50 0.35 0.45 0.30 0.66 1.00
ST-V4 0.62 0.70 0.52 0.63 0.19 0.64 0.87 1.00
ST-V5 0.70 0.81 0.62 0.75 0.04 0.53 0.70 0.91 1.00
ST-V6 0.69 0.87 0.70 0.82 -0.10 0.39 0.53 0.75 0.92 1.00
He et al. Environmental Health 2010, 9:68
http://www.ehjournal.net/content/9/1/68
Page 3 of 10allows us to explicitly model the expected correlation
between measurements taken from the same participant.
As the measurements are equally spaced, we used the
natural choice for correlation structure, autoregressive
order one (AR1), throughout the analyses to account for
the potential autocorrelation. A second-degree polyno-
mial for the distributed lag model was used because the
amount of variability in the outcomes of interest
explained by the air pollution measures is not large, so
that the degree of polynomial must be chosen parsimo-
niously. In our experience, second-degree polynomials
perform adequately, which is supported by Schwartz
[23]. Another advantage of the distributed lag model is
its ability to provide interpretation of the cumulative
effects of the lags included in the model, as well as indi-
vidual lag effects. Because the PM2.5 and ECG variables
were assessed in parallel over 48 lags (24 hour), we
decided a prior to model no more than ten lags, which
allowed us to fit the distributed lag model using at least
75% of the data. We started from the largest number of
lags (lag 0-10), and reduced the total number of indivi-
dual lags by back-eliminating the longer lags (e.g., lag
10) one lag at a time until a significant cumulative effect
on ST-II was identified (lag 4 in this report). We then
identified this model as our final model for all ST-height
measurements. All results are expressed per 10 μg/m
3
increase in PM2.5. In the distributed lag models, basic
demographic variables were included as the first step of
covariable adjustment. We then included additional
adjustment for diabetes, hypertension and CVD. To
examine the impact of CAM on PM2.5 and ST-height
associations, we repeated the models by adjusting for
each of the HRV variables. In these models, all time-
dependent covariables, such as weather and HRV vari-
ables, were entered in the model using the same distrib-
uted lag structure as the PM2.5 variable. We used SAS
statistical version 9 (SAS Institute, Inc., Cary, NC) for
all analyses.
Results
The demographic and cardiovascular disease risk pro-
files of the study population are presented in Table 2.
The mean age of the participants was 56 years, with
74% non-Hispanic white, 26% minorities (including
Blacks, Hispanics, and Chinese), 59% female, and 43%
having chronic diseases (primarily hypertension). The
prevalence of hypertension, diabetes, and CVD were
34.9%, 7.6%, and 8.5% respectively. At the population
level, the distribution of both PM2.5 exposure and ST-
height measures are approximately normal. The ST-
height measures are significantly lower in subjects with
chronic disease. Figure 1 and 2 show the time-of-the-
day-specific distributions (mean, 10
th and 90
th percen-
tile) of the PM2.5 a n dS T - h e i g h tf r o ml i m bl e a dI I( S T -
II), as an example of ST-height measures. Both the
PM2.5 and ST-height showed sufficient variation within
24 hours, and within time frame between individuals.
The cumulative effect and individual lag effects of
PM2.5 on each of the ST-height measures are summar-
ized in Table 3 as multivariable-adjusted regression
coefficient b (95% CI) associated with a 10 μg/m
3 incre-
ment of PM2.5 exposure. In summary, five leads (ST-I,
II, III, aVF, and ST-V6), out of ten ECG leads analyzed,
showed a significant positive association between PM2.5
exposure and ST-height. Examining the cumulative
effect, most of the adverse effect occurred within two
hours (lag0-4) after the elevation of PM2.5. Specifically,
the cumulative effect due to a 10 μg/m
3 increase in Lag
Table 2 Demographic characteristics and health status of
the study population
Characteristic All subjects Hypertension, Diabetes, or CVD
No Yes P value
N = 106 N = 60 N = 46
Age 56.2 (7.6) 55.6 (8.2) 57.1 (6.8) 0.30
Gender (% Male) 40.6 40.0 41.3 0.89
Race (% White) 73.6 71.7 76.1 0.61
Glucose (mg/dL) 88.8 (25.1) 84.6 (10.0) 94.3 (36.0) 0.09
BMI (kg/m2) 27.7 (5.9) 26.2 (4.3) 29.7 (7.0) <0.01
CVD (%) 8.5 0.0 19.6 <0.01
Hypertension (%) 34.9 0.0 84.8 <0.01
Diabetes (%) 7.6 0.0 17.4 <0.01
Systolic BP(mm Hg) 121.9 (15.7) 117.1 (11.9) 128.2 (17.9) <0.01
Diastolic BP (mm Hg) 75.1 (9.2) 73.1 (8.3) 77.6 (9.8) 0.01
College or higher (%) 78.3 73.3 84.8 0.16
Inferior Leads
ST-II (μV) 35.4 (38.0) 40.7 (38.0) 28.5 (7.0) <0.01
ST-III (μV) 19.4 (30.6) 22.5 (31.8) 15.4 (28.5) <0.01
ST-aVF (μV) 27.4 (33.5) 31.6(34.2) 22.0 (31.7) <0.01
Lateral Leads
ST-I (μV) 15.5 (17.1) 17.8 (15.3) 12.6 (18.9) <0.01
ST-V5 (μV) 46.8 (48.6) 55.0 (50.7) 36.1 (43.5) <0.01
ST-V6 (μV) 28.2 (37.7) 34.4 (38.5) 20.1 (25.3) <0.01
Septal Leads
ST-V1 (μV) 40.9 (31.9) 41.4 (33.2) 40.4 (30.1) 0.29
ST-V2 (μV) 90.64 (56.09) 94.3 (56.0) 86.0 (55.9) <0.01
Anterior Leads
ST-V3 (μV) 91.8 (65.5) 100.3 (71.3) 80.8 (55.2) <0.01
ST-V4 (μV) 72.5 (56.8) 81.7 (58.5) 60.7 (52.4) <0.01
PM2.5(μg/m
3) 13.6 (21.6) 11.9 (14.7) 15.9 (28.0) <0.01
Temperature (°C) 21.8 (3.5) 21.8 (3.7) 21.7 (3.4) 0.04
Relative humidity (%) 39.7 (12.1) 40.2 (12.3) 39.0 (11.8) <0.01
Results are presented as mean (SD) for continuous variables and percentage
for categorical variables.
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were 0.29 (0.01-0.56) μV, 0.79 (0.20-1.39) μV, 0.52
(0.01-1.05) μV, 0.65 (0.11-1.19) μV, and 0.58 (0.07-1.09)
μV, respectively. To visualize the acute effect of PM2.5
exposure on ST-height and its time course, both indivi-
dual and cumulative effects of lag 0-4 PM on ST-II
height are presented in Figure 3, as an example. Based
on the cardiac anatomy, we find that all inferior leads
(II, III, and aVF) and two out of three lateral leads (I
and V6) show significant ST-height elevation. Therefore,
our results also indicate that acute PM2.5 exposure lead
to regional cardiac ischemic changes. Our data also
revealed a less consistent individual lag effect. Addi-
tional adjustment for chronic disease did not change the
pattern of association from the models adjusted only for
major demographic and weather-related variables.
The statistically significant final multivariable-adjusted
models (M2, in Table 3) were repeated with additional
adjustment for heart rate variability variables, one HRV
variable at a time. The HRV adjusted regression coeffi-
cients measuring the cumulative effects of PM2.5 from
0-4 lags after adjusting for HRV variables are presented
Figure 1 Time Specific Distribution of PM2.5 Exposure over 24 Hours in the APACR Study.
Figure 2 Time Specific Distribution of ST-II Height over 24 Hours in the APACR Study.
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3 increment of PM2.5 concentration.
ST Variable Lag0 95% CI Lag1 95% CI Lag2 95% CI Lag3 95%CI Lag4 95% CI Cumulative 95% CI
Inferior Leads
ST-II M1 0.04 (-0.12,0.20) 0.13 (0.02,0.24) 0.19 (0.05,0.33) 0.21 (0.04,0.38) 0.19 (-0.12,0.50) 0.76 (0.17,1.36)
M2 0.04 (-0.12,0.20) 0.14 (0.03,0.25) 0.20 (0.06,0.33) 0.22 (0.05, 0.38) 0.20 (-0.11,0.51) 0.79 (0.20,1.39)
ST-III M1 0.02 (-0.13,0.16) 0.08 (-0.01,0.18) 0.13 (0.01,0.25) 0.14 (-0.01,0.30) 0.14 (-0.14,0.41) 0.50 (-0.02,1.03)
M2 0.02 (-0.12,0.16) 0.09 (-0.01,0.18) 0.13 (0.01,0.25) 0.15 (0.01,0.30) 0.14 (-0.13,0.41) 0.52 (0.01,1.05)
ST-aVF M1 0.03 (-0.12,0.18) 0.11 (0.01,0.21) 0.16 (0.03,0.28) 0.17 (0.02,0.33) 0.16 (-0.12,0.44) 0.63 (0.06,1.17)
M2 0.03 (-0.11,0.18) 0.11 (0.01,0.21) 0.16 (0.04,0.28) 0.18 (0.03,0.33) 0.17 (-0.11,0.45) 0.65 (0.11,1.19)
Lateral Leads
ST-I M1 0.03 (-0.05,0.10) 0.05 (0.01,0.10) 0.06 (0.01,0.13) 0.07 (-0.01,0.15) 0.06 (-0.08,0.21) 0.27 (-0.01,055)
M2 0.03 (-0.05,0.10) 0.05 (0.01,0.10) 0.07 (0.01,0.13) 0.07 (-0.01,0.15) 0.07 (-0.08,0.21) 0.29 (0.01,0.56)
ST-V5 M1 -0.01 (-0.20,0.17) 0.05 (-0.08,0.17) 0.10 (-0.05,0.26) 0.15 (-0.04,0.34) 0.19 (-0.16,0.54) 0.48 (-0.20,1.15)
M2 -0.01 (-0.19,0.18) 0.06 (-0.07,0.18) 0.11 (-0.04,0.27) 0.16 (-0.03,0.35) 0.20 (-0.15,0.55) 0.52 (-0.16,1.20)
ST-V6 M1 -0.01 (-0.14,0.13) 0.04 (-0.05,0.14) 0.10 (-0.02,0.55) 0.17 (0.02,0.31) 0.25 (-0.02,0.51) 0.55 (0.04,1.06)
M2 0.01 (-0.14,0.14) 0.05 (-0.05,0.14) 0.10 (-0.01,0.22) 0.17 (0.03,0.32) 0.25 (-0.01,0.52) 0.58 (0.07,1.09)
Spetal Leads
ST-V1 M1 -0.01 (-0.16,0.15) 0.05 (-0.06,0.15) 0.08 (-0.05,0.21) 0.08 (-0.08,0.25) 0.06 (-0.23,0.36) 0.26 (-0.31,0.83)
M2 -0.01 (-0.16,0.15) 0.05 (-0.06,0.15) 0.08 (-0.05,0.21) 0.09 (-0.08,0.25) 0.07 (-0.23,0.36) 0.27 (-0.30,0.84)
ST-V2 M1 -0.07 (-0.31,0.17) 0.11 (-0.04,0.27) 0.22 (0.02,0.42) 0.24 (0.01,0.49) 0.19 (-0.27,0.64) 0.69 (-0.17,1.56)
M2 -0.06 (-0.30,0.17) 0.12 (-0.04,0.28) 0.22 (0.02,0.42) 0.25 (0.01,0.50) 0.19 (-0.26,0.65) 0.72 (-0.14,1.59)
Anterior Leads
ST-V3 M1 -0.11 (-0.43,0.21) 0.06 (-0.15,0.27) 0.14 (-0.13,0.40) 0.12 (-0.21,0.05) 0.01 (-0.61,0.62) 0.20 (-0.94,1.35)
M2 -0.09 (-0.41,0.23) 0.08 (-0.13,0.29) 0.16 (-0.11,0.43) 0.14 (-0.19,0.47) 0.04 (-0.58,0.65) 0.33 (-0.82,1.47)
ST-V4 M1 -0.09 (-0.27,0.09) 0.03 (-0.09,0.16) 0.11 (-0.04,0.26) 0.14 (-0.05,0.33) 0.13 (-0.21,0.48) 0.33 (-0.34,1.00)
M2 -0.08 (-0.26,0.10) 0.04 (-0.09,0.16) 0.12 (-0.04,0.27) 0.15 (-0.04,0.34) 0.14 (-0.20,0.49) 0.37 (-0.30,1.04)
M1: Adjusted for age, sex, race, temperature, and relative humidity
2: Adjusted for age, sex, race, temperature, and relative humidity, diabetes, hypertension, and CVD
Figure 3 Effect of 10 μg/m
3 Increase in Lag 0-4 PM2.5 Exposure on ST-II.
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tions between PM2.5 and ST-height did not change sub-
stantially with additional adjustment for HRV variables
as measures of cardiac autonomic modulation. There-
fore, the ST-segment elevation we observed is indepen-
dent of sympathetic and parasympathetic nervous
activity.
We tested the interaction terms between PM2.5 and
chronic condition, and none were statistically significant
at the 0.05 level (data not shown). Therefore, the effects
of PM2.5 o nS T - h e i g h td i dn o td i f f e rd e p e n d i n go n
whether a person had previous health problems. We
also performed stratified analysis according to chronic
disease status, using M1 in Table 3. We found similar
associations by chronic disease status (data not shown).
It should be noted that the sample size of this study is
small, and individuals with chronic conditions consisted
mostly of well-controlled hypertensives. Therefore, the
statistical power was limited to detect significant effect
modification by chronic disease status.
Discussion
A large number of epidemiologic studies have found an
association between short-term exposure to increased
particulate air pollution and CVD morbidity and mortal-
ity [1-4,26,27]. However, the mechanisms responsible for
such an association have not been fully identified. Pre-
vious studies have suggested several promising underly-
ing mechanisms, including cardiac autonomic
impairment as measured by lower HRV [13,28-32], ven-
tricular repolarization [5,14,33-37], arrhythmia [38-41],
and myocardial ischemia [6-9,42]. The actual time-
course from PM exposure to effects on cardiac measures
has not been investigated systematically in a commu-
nity-based sample. Cavallari and coworkers reported an
early- and a later-phase HRV response, with the early
effects at two hours and delayed effects at nine to thir-
teen hours after exposure [43]. We reported a sub-acute
PM2.5 effect on HRV at approximate in four to six
hours [13], and an acute PM2.5 effect on ventricular
repolarization at three to four hours [14]. No studies to
date have investigated whether the PM and myocardial
ischemia association is mediated through its adverse
effects on other ECG parameters, such as CAM.
In this study of community-based individuals, we
examined the acute effect and time course of PM2.5 on
myocardial ischemia. However, we did not limit our
examination to the characteristics of clinically manifest
ischemia (e.g. ≥ 100 μV for limb leads and ≥ 200 μVf o r
precordial leads of ST-segment elevation), since air pol-
lution could possibly induce ischemic changes to a les-
ser degree. Our results reveal that PM2.5 had a
significant positive effect on ST-height from five out of
ten leads, supporting that elevated PM2.5 levels can lead
to higher ST-height in inferior and lateral leads, which
can be considered as indications of potential for regional
myocardial ischemic damage. These findings are consis-
tent with previous reports [6-9,42], and extend the
adverse PM2.5 effects from special populations to a com-
munity-based sample of healthy individuals, and from
ambient-based estimated PM exposures to individual-
level measured exposures to PM.
We examined whether the PM and ST-height relation-
ship is chiefly mediated through its adverse effect on
CAM. As evidenced by the results presented in Table 4,
the PM and ST-height associations in all five leads
remained unchanged after adjusting for HRV variables
as measures of CAM. Thus, our data did not support
that the PM2.5 and myocardial ischemia association was
majorly mediated through its adverse effects on CAM,
at least not from the same lagged effects that we ana-
lyzed. However several other mechanisms could explain
the adverse effects of PM on myocardial ischemia. First,
PM may induce a constriction in the coronary artery.
Supporting this hypothesis, Brook and coworkers
reported a sudden conduit vasoconstriction after a
short-term PM2.5 and O3 exposure in a sample of
healthy volunteers [44]. Mills and coworkers also
reported similar patterns supporting the vascular dys-
function effects of PM exposures [45]. Second, PM may
also decrease the oxygen-carrying capacity of the blood,
as supported by studies reported by several investigators
[46-48]. Third, it is also possible that the ST-height
changes in response to elevated PM2.5 in parallel to its
Table 4 HRV adjusted Lag0-4 cumulative effect of ST-height associated with 10 μg/m
3 increment of PM2.5.
ST Variable Regression Coefficients (SE) and 95% CI
Log-HF 95% CI Log-LF 95%CI SDNN 95% CI RMSSD 95% CI
ST-I 0.31 (0.03,0.58) 0.31 (0.03,0.58) 0.29 (0.02,0.57) 0.31 (0.03,0.58)
ST-II 0.77 (0.24,1.30) 0.77 (0.24,1.30) 0.73 (0.20,1.26) 0.78 (0.25,1.31)
ST-III 0.47 (0.02,0.92) 0.47 (0.02,0.92) 0.45 (0.01,0.90) 0.48 (0.03,0.93)
ST-aVF 0.61 (0.14,1.08) 0.61 (0.14,1.08) 0.58 (0.11,1.05) 0.62 (0.15,1.10)
ST-V6 0.57 (0.07,1.08) 0.57 (0.07,1.08) 0.56 (0.05,1.06) 0.58 (0.07,1.08)
Adjusted for age, sex, race, temperature, relative humidity, diabetes, hypertension, CVD, and each of the HRV indices.
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lar to the electrophysiological changes seen in Brugada
Syndrome, which is associated with high incidence of
sudden cardiac death [49] by means of alternation in
repolarizing currents presented on ECG as lower HRV
and ST-segment elevation in the right precordial ECG
leads V1-V3. Lastly, it is also plausible that PM has a
direct adverse effect on cardiac electrophysiological
parameters, such as ST-height. More mechanistic stu-
dies are needed to investigate the exact pathways from
PM exposure to the adverse cardiac electrophysiological
effects.
O nt h et i m ec o u r s eo fP M 2.5 effects on myocardial
ischemia measures, our data consistently indicate that
t h et i m ec o u r s eo ft h ea d v e r s ee f f e c ti sw i t h i nf o u rl a g s
o ft h ee x p o s u r ew i n d o w-a p proximately two hours of
elevated PM2.5 exposure, similar to that reported by
Mills and coworkers [45] on the acute effects of diesel
exhaust on vascular dysfunction and impaired endogen-
ous fibrinolysis. Our findings on the time-course of
PM2.5 effects on ischemia are also consistent with that
reported by Cavallari and coworkers [43] on the early
effects of PM exposure on HRV. In the same popula-
tion, time course of PM2.5 effects on myocardial ische-
mia measures are more acute than the effects on HRV
[13] and on ventricular repolarization [14]. To our
knowledge, this is the first study to demonstrate the
time-course of the acute effects of PM2.5 on myocardial
ischemia in healthy middle aged individuals sampled
from communities.
It is worthwhile noting that most of the effect sizes of
individual lags within the two hour time frame (lag0-
lag4) are smaller than the cumulative effects. As
expected, some of the associations between individual
lag PM exposure and ST-height are not statistically sig-
nificant. While individual lag effects may be too small to
show an important contribution to the ST-height, the
sum of such small effects is large enough to show a sig-
nificant impact on the ST-height measures. This can be
clearly illustrated by Figure 3 as well. On the other
hand, the cumulative effect sizes we identified in this
study are also relatively small. For example, for every 10
μg/m
3 increase in Lag 0-4 PM2.5 exposure, the asso-
ciated increases in ST-II is only 0.79 μV, corresponding
to 2% increase in this variable, which has a mean of 35
and SD of 38 μV. Therefore, such small effects on ST-
height may not be clinically meaningful. On the other
hand, it can be argued that the entire population is
exposed to PM2.5 on a continuous basis daily. Thus, ele-
vated PM2.5 levels can have a huge public health impact.
Moreover, the minor effect observed in ST-height in
this study was measured in generally healthy individuals.
It is possible that PM2.5 effect on myocardial ischemia
might be greater in individuals with underlying
structural heart disease or ischemic heart disease. Future
studies should target these clinical subgroups likely to
be more susceptible to the effects of PM2.5,e s p e c i a l l y
t h o s em a d em o r ev u l n e r a b l eb yr e s i d i n gn e a rs o u r c e so f
PM2.5, e.g. highways.
There are several limitations. First, the APACR study
excluded smokers and persons with acute cardiac events
within the past six months. Thus, our findings may not
apply to smokers or persons with a recent acute cardiac
event. Second, the majority of participants reported that
they stayed indoors most of the time during the 24-hour
study period, except when they had to travel by automo-
bile. This behavior pattern is reflected in the relatively
low levels of exposure to PM2.5. In general, our partici-
pants had limited indoor exposures, such as second-
hand smoking. Thus, we were unable to assess whether
exposures at much higher levels would exhibit similar
associations. However, we purposely used the personal
monitors and real-time Holter system to collect the true
individual-level exposure and routine ECG data, respec-
tively. We argue that the associations we observed in
these individuals are more reflective of their routine
exposure and outcome associations. Third, the ECG
data from Holter were not collected under a controlled,
supine position setting. Thus, the short-term variation
of other factors that may impact the ST-height cannot
be fully accounted for. However, our study captures the
range of activities occurring in real life, including time
spent outdoors, time spent commuting in automobile,
and various other activities associated with a disease-
free community-based individual. Lastly, the pDR esti-
mated PM2.5 concentrations over 24 hours were used in
this study as an estimation of personal exposures. This
nephelometric device responds to the optical properties
of the particles it encounters rather than the true parti-
cle gravimetric properties. Its h o u l db er e c o g n i z e dt h a t
the optical properties calibrated using Arizona road dust
might not be highly representative of the actual PM2.5
aerosol the study participants encountered. Previous stu-
dies have reported that the Arizona road dust calibrated
pDR, identical to the one used in this study, provides a
mass concentration estimate in good agreement with
that from gravimetric mass-based measures (correlation
coefficients > 0.8), but the pDR often yield estimates 10-
50% higher than that from a gravimetric mass-based
measures[15,16,18]. Based on these validation studies,
the personal exposures used in this study might slightly,
but systematically, overestimate the true environmental
conditions that existed. However, such a systematic
overestimation of the true exposures to PM2.5 should
not have biased the pattern of the observed associations.
It can be argued that the reported effect sizes per 10
μg/m
3 increase in the pDR estimated PM2.5 actually
represented effect sizes of only 5.00 - 9.00 μg/m
3
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cally overestimates the true exposure by 10-50%, i.e., the
reported effect sizes in this study were systematically
underestimated.
Conclusions
In summary, acute exposure to PM2.5 at the individual
level, is directly associated with higher ST-height mea-
sures in inferior and lateral leads, which is indicative of
regional ischemic damage potential to the myocardium.
Moreover, the time to effects is about two hours after
elevated PM2.5. The effect of PM on ST-height is inde-
pendent of major confounding factors and cannot be
attributed solely to its effects on HRV as measures of
CAM. Overall, these findings support that PM may
affect myocardial ischemia, and partly through such a
mechanism, PM increases cardiovascular risk, such as
sudden cardiac death and myocardial infarction.
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